PT  - JOURNAL ARTICLE
AU  - Schadendorf, Dirk
AU  - Luke, Jason John
AU  - Ascierto, Paolo A
AU  - Long, Georgina V
AU  - Rutkowski, Piotr
AU  - Khattak, Adnan
AU  - Del Vecchio, Michele
AU  - de la Cruz-Merino, Luis
AU  - Mackiewicz, Jacek
AU  - Sileni, Vanna Chiarion
AU  - Kirkwood, John M
AU  - Robert, Caroline
AU  - Grob, Jean-Jacques
AU  - Dummer, Reinhard
AU  - Carlino, Matteo S
AU  - Zhao, Yujie
AU  - Kalabis, Mizuho
AU  - Krepler, Clemens
AU  - Eggermont, Alexander
AU  - Scolyer, Richard A
TI  - Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial
AID  - 10.1136/jitc-2023-007501
DP  - 2024 Mar 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e007501
VI  - 12
IP  - 3
4099  - http://jitc.bmj.com/content/12/3/e007501.short
4100  - http://jitc.bmj.com/content/12/3/e007501.full
SO  - J Immunother Cancer2024 Mar 01; 12
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.